Background {#Sec1}
==========

The prevalence of hypocalcemia following thyroidectomy and central compartment lymph node dissection (CND) for papillary thyroid cancer (PTC) is high, with overall rates of 25% transient and 3% permanent \[[@CR1]\]. This may be a result of manipulation of the parathyroid gland or devascularization, or may be caused by inadvertent removal along with the thyroid specimen \[[@CR2]--[@CR7]\].

Biochemical studies of post-thyroidectomy patients have shown that intact parathyroid hormone (iPTH) sampling is a valid, early predictor of the postoperative parathyroid gland state \[[@CR1]\]. Limited data is available for assessing the state of the parathyroid following CND in endoscopic thyroidectomy \[[@CR1]--[@CR11]\].

This study aims to compare the kinetics of iPTH in the perioperative period of endoscopic thyroidectomy via bilateral areola approach (ETBAA) with the same period following a traditional open thyroidectomy approach (OTA).

Methods {#Sec2}
=======

Study design {#Sec3}
------------

Patients who had undergone total thyroidectomy and CND for thyroid cancer with postoperative iPTH evaluation were prospectively observed between October 2013 and April 2018. All participants gave informed consent before research commenced. The study was conducted in accordance with the Declaration of Helsinki, while the protocol was approved by the ethics committee of China-Japan Union Hospital of Jilin University (see protocol n. 2012-wjw-004).

Setting {#Sec4}
-------

Research took place at the Academic Hospital, which is a single institutional, tertiary referral center.

Participants {#Sec5}
------------

Patients who had undergone thyroidectomy without CND, concomitant parathyroid disease, renal failure, unilateral lobectomy, 'berry picking' dissection, re-done central neck dissections, high or low basal iPTH values (normal range 15-65 pg/ml) were excluded from analysis. Patients with vitamin D deficiency or preoperative calcium supplementation were also excluded. Inclusion and exclusion criteria for ETBAA can be seen in Table [1](#Tab1){ref-type="table"}. The study only included patients with a malignant thyroid disease. Cancer patients were placed into three groups: (A) patients who were eligible for endoscopic treatment and who accepted ETBAA (ETBAA); (B) patients eligible for ETBAA yet who opted for OTA (OTA-L); (C) those cancer patients who were ineligible for endoscopic intervention who had undergone OTA (OTA-H). The inclusion criterion was cN0 on clinical and US examination for the ETBAA and OTA-L group, while those from the OTA-H group were ineligible for endoscopic intervention, including cN1. See Fig. [1](#Fig1){ref-type="fig"} for a grouping flow chart. Patients could be included if they had PTC, been diagnosed preoperatively using cytological diagnosis, were diagnosed with N0 neck either clinically or following ultrasonography (US), and those whose diagnosis had been confirmed following intraoperative inspection. Table 1Detailed inclusion and exclusion criteria for ETBAASelection and Exclusion criteriaSelection criteria Papillary thyroid cancer with low-risk factors^a^ Dominant benign nodule with a diameter \< 5 cm, whereas cystic nodule could be 6 cm or greater The patients needed a cosmetic requirementExclusion criteria General factors  Obesity and stocky neck  Clinical history of radiation or surgery on the neck or chest  Preoperative dysfunction of voice cord Thyroid-related factors  Advanced cancer  Local invasion  Posteriorly located lesions  Diffuse or adhesion or fixation enlargement of lymph node  Evidence available of local or distant metastases  Graves' disease  Severe thyroiditis  Associated parathyroid disease^a^Low risk factors including lesion size \< 4 cm, age \< 55 years, no prior radiation, no distant metastases, no lymph node metastases, no extrathyroidal extension, no aggressive variant, and no first-degree family history of thyroid carcinoma Fig. 1Flow chart for subgroup analysis. Patients eligible for endoscopic treatment, who accepted ETBAA were confined in Group ETBAA; patients eligible for ETBAA, who opted for traditional intervention in Group OTA-L; non-candidates for endoscopic intervention, who underwent open thyroidectomy were included in Group OTA-H

Definitions and interventions {#Sec6}
-----------------------------

All participants were subjected to preoperative high-resolution US \[[@CR12]\]. The 2009 Bethesda classification system of thyroid cytopathology was utilized \[[@CR12]\]. Non-contrast slides from CT scans were frequently utilized during the initial evaluation of a solitary thyroid cancer.

Surgical technique {#Sec7}
------------------

The ETBAA technique has been previously described (Additional file 1: Video S1) \[[@CR13]\]. The third and fourth intercostal incisions of male ETBAA patients are conventionally used for the endoscopic access. The middle incision is 12 mm, and the bilateral incisions are approximately 5--6 mm. The central neck dissection (level VI) is then performed similarly to that of women patients. Standardized neural monitoring was implemented in all groups \[[@CR13]\]. All surgeries were performed by the same endocrine surgeon (DZ). Dissection and hemostasis were achieved in OTA with a Focus Plus device, and were achieved in ETBAA by means of an ACE plus device (Johnson & Johnson Company, Cincinnati, OH, USA). Drainage tubes were attached from the chest incision.

**Additional file 1: Video S1.** The procedure of protection and autotransplantation of parathyroid gland in ETBAA and open thyroid surgery. The video show that the ETBAA and open thyroid surgery should be carefully operated to protect parathyroid gland and its blood supply in situ as far as possible. The parathyroid gland with poor blood supply should be transplanted into sternocleidomastoid muscle in time.

Parathyroid gland scheme location and dissection {#Sec8}
------------------------------------------------

Preservation of the parathyroid glands as well as their blood supply was attempted in all cases. Efforts to identify all four glands also took place in all cases. However, an extensive neck exploration to search for one or two missing glands was not carried out. A classification scheme for parathyroid glands location was utilized (see Fig. [2](#Fig2){ref-type="fig"}). Type A: the gland is firmly fixed to thyroid gland. Type A can be grouped into three subtypes. A1: the parathyroid gland is attached to the inherent thyroid capsule. A2: the gland is partially embedded in thyroid gland. A3: the gland is located in thyroid tissue and is discovered after thyroid gland excision. Type B can be defined as a gland which is separate from the thyroid gland \[[@CR14]\]. Fig. 2Design and intraoperative pictures of the dedicated localization scheme we used to describe the relationship between the parathyroid gland and the thyroid gland. Type A: parathyroid gland is tight, closely related to the thyroid gland. Type A is divided into three subtypes. **a** Type A1, parathyroid gland is attached to the surface of thyroid gland; **b** type A2, parathyroid gland partially or completely embedded in the thyroid gland, but located outside the inherent capsule of the thyroid; **c** type A3, the parathyroid gland is completely located in the thyroid tissue. **d** Type B is distant from the thyroid gland

Parathyroid autotransplantation {#Sec9}
-------------------------------

In cases where the parathyroid glands had been damaged, auto-transplantation was undertaken. Prior to auto-transplantation, a section of a fragment of the parathyroid gland was frozen. Parathyroid tissue was stored in a saline solution after excision. Sliced parathyroid tissue and 1 ml of saline was withdrawn into a syringe and injected into the monolateral sternocleidomastoid muscle (Additional file 1: Video S1).

Technique for CND {#Sec10}
-----------------

The techniques for CND applied have been described previously \[[@CR8], [@CR15]--[@CR17]\].

iPTH and calcium determinations {#Sec11}
-------------------------------

iPTH measurements were assessed by chemiluminescence (STAT-Intraoperative-Intact-PTH, Future Diagnostics, Wijchen, Netherlands). Venous samples were obtained before surgery and at skin closure. According to our protocol, if iPTH was \< 15 pg/mL, then the subject received oral calcium and vitamin D substitution \[[@CR15]--[@CR17]\]. Serum calcium (range 2.2 to 2.6 mmol/L) was monitored at 24, 48, 72 h and + 15 days postoperatively. On follow-up visits at + 1, 3 and 6 months, both the serum calcium and the iPTH level were verified \[[@CR15]--[@CR17]\]. If two consecutive serum calcium determinations were within or above the normal value, then firstly calcium and secondly vitamin D were no longer given \[[@CR15]--[@CR17]\].

Follow-up {#Sec12}
---------

Pre- and postoperative follow-up included laryngoscopy \[[@CR15]--[@CR17]\]. Measurement of serum Thyroglobulin, stimulated thyroglobulin hormone (TSH) and thyroglobulin antibodies were monitored in all patients after surgery in the follow up period \[[@CR15]--[@CR17]\]. After surgery, patients were given TSH-suppressive L-thyroxine therapy \[[@CR12]\]. The seventh edition of the AJCC/TNM cancer staging system was used \[[@CR12]\]. Papillary thyroid cancer indications for RAI treatment (4--5 weeks after surgery) include: \> 45 years or \< 18 years; tumor \> 2 cm; thyroid capsule, soft tissue, adjacent organ tumor extension; LN+ (in any area of the neck); non-classical variants of PTC; M+; remnant ablation; BRAF+.

Neither profiles of thyroglobulin, TSH and thyroglobulin antibodies nor prevalence/dose of RAI analysis are the purpose of this preliminary report.

Primary outcome {#Sec13}
---------------

iPTH kinetics in ETBAA versus open surgery were considered as the primary end-point.

Statistics {#Sec14}
----------

PTH \< 15 pg/ml was utilized for statistical testing \[[@CR15]--[@CR17]\]. The cut-off value for the serum calcium level was 2.0 mmol/L \[[@CR7], [@CR15]--[@CR17]\]. Analysis of the data was calculated using SPSS version 19.0 (SPSS Inc., Chicago, USA) and SAS version 9.4 (SAS Inc., North Carolina, USA). Data were presented as mean ± standard deviation. The differences between parathyroid gland outcomes, changes of PTH perioperative or serum calcium and calcium supplementation in the ETBAA, OTA-L and OTA-H groups were analyzed using Cochran's and Mantel-Haenszel Chi-square test. The level of statistical significant was 0.05.

Results {#Sec15}
=======

Data collection analysis {#Sec16}
------------------------

Over the six-year period of the study, 315 patients underwent total thyroidectomy and CND as a one-stage procedure. Figure [3](#Fig3){ref-type="fig"} depicts a flow chart with the number of patients eligible and not eligible for the study. Based on the selection and exclusion criteria, 300 patients were eligible for the study. These were 44 men and 256 women, aged 16--54 years (median 37.7). Demographic, clinical, laboratory, operative, morbidity and histology data can been seen in Table [2](#Tab2){ref-type="table"}. Mean length of follow-up was 20 ± 6 months (range five to 52 months). No instances of instrument malfunction (neuromonitoring, endoscopy, ultrasound scalpel and so on) were recorded in this study. Fig. 3Flow diagram inclusion and intervention for the study Table 2Patients characteristicsETBAA\
(*N* = 100)OTA-L\
(*N* = 100)OTA-H\
(*N* = 100)Age ± SD (years)31.2 ± 9.3136.2 ± 10.547.9 ± 15.7Gender (M/F)11/8916/8417/83Central lymph node dissection Prophylactic10010017 Therapeutic0083Mean operating time (min)124.8 ± 19.443.8 ± 9.2957.9 ± 12.23intraoperative blood loss (ml)7.02 ± 3.446.56 ± 3.248.31 ± 3.15Postoperative hospital stay time(D)3.88 ± 0.523.13 ± 0.764.02 ± 0.98Total drain volumes (ml)63.34 ± 21.225.18 ± 18.352.28 ± 16.9Mean draining days1.85 ± 0.421.39 ± 0.371.89 ± 0.62Parathyroid dysfunction (number)7615 Transient7512 Persistent013Hypocalcemia (number)91118 Transient91015 Persistent013Recurrent laryngeal injury (number)726 Transient724 Definitive002Histopathology papillary thyroid carcinoma100100100 Thyroid volume (mm^3^)7445 ± 4387562 ± 4928250 ± 509 Mean diameter of tumor (cm)0.89 ± 0.520.93 ± 0.432.85 ± 1.83 Extracapsular invasion(+/total)0/1000/10043/100 Parathyroid in specimen437 Coexistence thyroiditis91122 Mean number of LN(n)7.78 ± 2.032.99 ± 1.5310.3 ± 3.4 Mean Metastatic (n)2.17 ± 3.120.77 ± 1.293.47 ± 4.08N is the number of patients in the different groupsData, which fitted the normal distribution, were presented as Mean ± SD

Comparative study {#Sec17}
-----------------

There were 100 patients in each group. In the ETBAA group, mean age was 31.2 ± 9.31, and there were 11 male and 89 female participants. In the OTA-L group, mean age was 36.2 ± 10.5, and there were 16 male and 84 female patients. In the OTA-H group, mean age was 47.9 ± 15.7, while there were 17 male and 83 female participants. The only significant difference between the ETBAA and OTA-L groups was the mean operating time and drainage (Table [2](#Tab2){ref-type="table"}). The preoperative TSH (*P* = 0.17) and tireoglobulin levels (*P* = 0.26) were seen to be within the normal range for both groups. None of the patients in the study population had a preoperative recurrent laryngeal nerve (RLN) palsy. There was no significant difference found between the incidence of hypoparathyroidism (permanent 0% versus 1%; transient 7% versus 5%) and hypocalcemia (permanent 0% versus 1%; transient 9% versus 10%) (Table [2](#Tab2){ref-type="table"}). A comparison of the ETBAA and OTA-H groups and of the OTA-L and OTA-H groups found that the mean tumor diameter, rate of extracapsular invasion and number of lymph node metastases were significantly different and were positively correlated with both hypoparathyroidism and hypocalcemia following surgery (Table [2](#Tab2){ref-type="table"}). The endoscopic group were treated during an earlier stage of thyroid cancer. Regarding RLN injury, both transient and permanent unilateral palsy were found in the ETBAA group at 7% versus 0%, the OTA-H group at 4% versus 2% and the OTA-L group at 2% versus 0% (*p* \> 0.05) (Table [2](#Tab2){ref-type="table"}). No cases of bilateral palsy were found.

Parathyroid gland identification, position and transplantation {#Sec18}
--------------------------------------------------------------

A significant difference was found between the ETBAA and OTA-H groups in parathyroid type A2, as well as a loss of parathyroid glands and a number of parathyroid transplantation procedures (*P* \< 0.05). Details are described in Table [3](#Tab3){ref-type="table"} and Fig. [4](#Fig4){ref-type="fig"}. Table 3Parathyroid glands outcomesETBAAOTA-LOTA-HNumber of glands identified 1001 2345 3686 4918888 Total388384381Location of glands identified Superior200/200\*\*197/200194/200 ^\#^ Inferior188/200187/200187/200 Right side191/200191/200192/200 Left side197/200\*193/200189/200^\#^ Superior right100/10099/10098/100 Superior left100/100\*98/10096/100^\#^ Inferior right91/10092/10094/100 Inferior left97/10095/10093/100Parathyroid gland scheme Type A358/388363/384351/381 A1284/388275/384256/381 A273/388\*86/38492/381^\#^ A31/3882/3843/381 Type B30/38821/38430/381Incidental parathyroidectomy Location of removed  Intrathyroidal1/3882/3843/381  Subcapsular6/3889/38412/381  Extracapsular0/388\*\*3/3847/381^\#^ Number of removed  17/3889/38415/381  20/388\*1/3842/381^\#^  30/3881/3841/381  Fragment0/3880/3840/381Auto-transplantation7/388\*\*14/38422/381^\#^\**P* \< 0.05, \*\**P* \< 0.01; analysis of the total three groups with Cochran's and Mantel-Haenszel Chi-square (χ~CMH~^2^) test, while the variable of side was controlled^\#^*P* \< α', analysis of group ETBAA and group OTA-H with χCMH2 test, α' = α/4 = 0.0125 Fig. 4Comparative analysis for parathyroid location and strategy. A1, parathyroid gland is attached to the surface of thyroid gland; A2, parathyroid gland partially or completely embedded in the thyroid gland, but located outside the inherent capsule of the thyroid; A3, the parathyroid gland is completely located in the thyroid tissue. B is distant from the thyroid gland, which is easier to preserve in situ. T, Intraoperative auto-transplantation of parathyroid gland. ^\#^P, Comparisons of groups between ETBAA and OTA-H

iPTH profile {#Sec19}
------------

No significant difference was found in preoperative iPTH values between the OTA-L, OTA-H and ETBAA groups (Table [4](#Tab4){ref-type="table"}, Fig. [5](#Fig5){ref-type="fig"}). Fifteen minutes following surgery, the iPTH profile of each group decreased, although this was most consistent in the OTA-H group (Fig. [5](#Fig5){ref-type="fig"}). No significant difference was found in iPTH between the ETBAA and OTA-L groups. There was a significant difference found between the OTA-H and ETBAA groups, and between the OTA-H and OTA-L groups (Table [4](#Tab4){ref-type="table"}). When comparing the ETBAA with OTA-L, the iPTH level change is similar. Table 4Changes of PTH before and after operationETBAAOTA-LOTA-HPreoperative (pg/mL)49.18 ± 23.1852.49 ± 20.3451.97 ± 3115 min postoperative (pg/mL)30.84 ± 17.55^\*\*^31.27 ± 22.66^£^23.01 ± 19.07^\#^\**P* \< 0.05, \*\**P* \< 0.01; analysis of the total three groups with Cochran's and Mantel-Haenszel Chi-square (χ~CMH~^2^) test, while the variable of side was controlled^\#^*P* \< α', analysis of group ETBAA and group OTA-H with χ~CMH~^2^ test, α' = α/4 = 0.0125^£^*P* \< α', analysis of group OTA-L and group OTA-H with χ~CMH~^2^ test, α' = α/4 = 0.0125 Fig. 5iPTH kinetics. P, Comparisons of Preoperative and 15 min postoperative in each group

Serum Ca and supplementation {#Sec20}
----------------------------

No significant difference was found in basal serum Ca values for the OTA-L, OTA-H and ETBAA groups (Fig. [6](#Fig6){ref-type="fig"}, Table [5](#Tab5){ref-type="table"}). On the first day following surgery, there was no significant difference found in serum Ca values between the OTA-L, OTA-H and ETBAA groups. No significant difference was found in calcium supplementation between the OTA-L and ETBAA groups. Fig. 6Serum Ca profile and supplementation. ^\#^P, Comparisons of groups between ETBAA and OTA-H; £P, Comparisons of groups between OTA-L and OTA-H Table 5Serum calcium and calcium supplementationETBAAOTA-LOTA-HPreoperative Calcium (mmol/L)2.32 ± 0.212.33 ± 0.192.29 ± 0.39 Supplementation (g)000First day postoperation Calcium (mmol/L)2.28 ± 0.322.35 ± 0.222.13 ± 0.37 Supplementation (g)2.56 ± 0.48^\*\*^2.59 ± 0.32^£^3.82 ± 0.46^\#^second day postoperation Calcium (mmol/L)2.21 ± 0.37^\*\*^2.27 ± 0.31^£^2.09 ± 0.41^\#^ Supplementation (g)1.89 ± 0.32^\*\*^1.93 ± 0.26^£^2.75 ± 0.41^\#^third day postoperation Calcium (mmol/L)2.25 ± 0.182.26 ± 0.192.18 ± 0.39 Supplementation (g)0.52 ± 0.61^\*\*^0.41 ± 0.61^£^1.83 ± 0.37^\#^\**P* \< 0.05, \*\**P* \< 0.01; analysis of the total three groups with Cochran's and Mantel-Haenszel Chi-square (χ~CMH~^2^) test, while the variable of side was controlled^\#^*P* \< α', analysis of group ETBAA and group OTA-H with χ~CMH~^2^ test, α' = α/4 = 0.0125^£^*P* \< α', analysis of group OTA-L and group OTA-H with χ~CMH~^2^ test, α' = α/4 = 0.0125

On day two after surgery, no difference was found in the serum Ca values of the OTA-L and ETBAA groups. However, a significant difference was discovered in serum Ca values between the OTA-H and ETBAA groups, as well as the OTA-H and OTA-L groups. There was also a difference in calcium supplementation between OTA-H and ETBAA groups as well as the OTA-H and OTA-L groups.

On the third day after surgery, no significant difference was found in the serum Ca values between the OTA-L, OTA-H and ETBAA groups. Statistical analysis found a positive correlation in calcium supplementation between the OTA-H and ETBAA groups as well as between the OTA-H and OTA-L groups (Table [5](#Tab5){ref-type="table"}, Fig. [6](#Fig6){ref-type="fig"}).

Histopathology {#Sec21}
--------------

Histopathology confirmed that all participants had suffered from PTC. There was a significant difference found in thyroid volume, mean diameter of tumor, extracapsular invasion, coexistence thyroiditis and level VI metastasis between the OTA-H and ETBAA groups as well as between the OTA-H and OTA-L groups (Table [2](#Tab2){ref-type="table"}). A significant difference was found in the mean number of lymph nodes dissected between the OTA-L and ETBAA groups as well as the OTA-L and OTA-H groups (Table [2](#Tab2){ref-type="table"}). Statistics found a positive correlation in the mean number of metastasis between the OTA-L and ETBAA groups as well as the OTA-L and OTA-H groups.

Discussion {#Sec22}
==========

We described parathyroid gland-related kinetics in the context of the current practices of both OTA and ETBAA. In this prospective observational study, 300 patients who had undergone thyroidectomy and central neck dissection were reviewed. Patients were stratified into three groups: those eligible for endoscopic treatment (ETBAA); patients who were eligible for ETBAA and had opted for OTA (OTA-L); and patients who were not suitable for endoscopic intervention (OTA-H). iPTH measurements for each patient were taken at pre-established points during the periods before and after surgery.

The iPTH profile of each group decreased, although this was the most consistent in the OTA-H group. When comparing the ETBAA with OTA-L, the iPTH level change is similar. Therefore, we can conclude that there is no advantage to using endoscopic treatment to preserve parathyroid function.

Thyroidectomy and CND are starting to be included in international guidelines \[[@CR8], [@CR12]\]. There is, therefore, an increased interest in the precise description of morbidity related to the procedures. Parathyroid gland preservation is recommended during ETBAA, as are other endocrine endoscopic and open techniques \[[@CR15]--[@CR17]\]. The dearth of studies which address the kinetics of iPTH during ETBAA led us to investigate hormone profile in comparison to well-standardized procedures such as OTA. We hypothesized that differences in iPTH kinetics may result in different thyroid gland approaches \[[@CR15]--[@CR17]\]. This is the first study to analyze the iPTH profile in ETBAA.

No other studies have compared the kinetics of iPTH levels after thyroidectomy and CND in ETBAA versus open surgery. Our study clarifies the kinetics of iPTH following 300 thyroidectomy and lymph node clearance procedures. The results of this study suggest the relevance of perioperative iPTH decline in CND for both open and endoscopic procedures. We have described a decrease between preoperative iPTH levels which is significantly related to the number of lymph nodes dissected, their metastatic status, and the type of parathyroid gland location.

Fifteen minutes after surgery, the iPTH profile of each group had decreased, although this was most consistent in the OTA-H group. No significant difference was found in iPTH between the ETBAA and OTA-L groups following surgery. However, there was a significant difference between the OTA-H and ETBAA groups as well as between the OTA-H and OTA-L groups. Perhaps the endoscopic magnification of the parathyroid glands during ETBAA has the potential to enhance gland preservation \[[@CR15]--[@CR17]\].

There are limitations to the present study. It is important to identify factors that cause interpatient variability in iPTH responses. A significant difference was found between ETBAA and OTA-H groups in parathyroid type A2, as well as a loss of parathyroid glands and a number of parathyroid transplantation procedures (Table [3](#Tab3){ref-type="table"} and Fig. [4](#Fig4){ref-type="fig"}). The significant differences we found may also be due to the selection of participants. Patients who are eligible for endoscopic surgery have less extensive disease and improved general factors when compared to other patients (Table [1](#Tab1){ref-type="table"}). This has the potential to contribute to a more difficult surgery in the open surgery group, which can in turn necessitate and lead to more extensive preparations during surgery, which then obviously increase the risk of damage to the parathyroid glands.

Conclusion {#Sec23}
==========

Patients with PTC were stratified into three groups: those eligible for ETBAA; those who were eligible for ETBAA yet opted for OTA (OTA-L); and those who were not suitable for endoscopic approach (OTA-H). The postoperative iPTH profile of each group decreased, although this was most consistent in OTA-H group. When comparing ETBAA and OTA-L, iPTH level profiles were similar. Thus, there is no advantage of endoscopic treatment over open surgery for preserving parathyroid function.

CND

:   Central compartment lymph node dissection

ETBAA

:   Endoscopic thyroidectomy via bilateral areola approach

iPTH

:   Intact parathyroid hormone

OTA

:   Open thyroidectomy approach

OTA-H

:   Ineligible for endoscopic intervention who had undergone OTA

OTA-L

:   Patients eligible for ETBAA yet who opted for OTA

PTC

:   Papillary thyroid cancer

TSH

:   Stimulated thyroglobulin hormone

US

:   Ultrasonography

**Publisher's Note**

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Nan Liang and Hui Sun contributed equally to this work.

Supplementary information
=========================

**Supplementary information** accompanies this paper at 10.1186/s12893-019-0656-8.

Not applicable.

Conception and design: HS, NL and GD; Administrative support: HS, NL and GD; Collection and assembly of data: DQZ; Data analysis and interpretation: All authors; Manuscript writing: All authors; Final approval of manuscript: All authors.

This study was funded by The National Nature Science Foundation of China (no. 81702651), China Postdoctoral Science Foundation (no. 2017 M611313), Department of Science and Technology of Jilin Province (no. 20170520018JH and 20190201225JC). These Funding provide financial support for this study, in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.

The datasets generated and/or analyzed during the current study are not publicly available due to protecting individual patient privacy but are available from the corresponding author on reasonable request.

All procedures performed in studies involving human participants were in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards, while the protocol was approved by the ethics committee of China-Japan Union Hospital of Jilin University (see protocol n. 2012-wjw-004). Informed consent of written was obtained from all individual participants included in the study.

Not applicable.

The authors declare that they have no competing interests.
